Zum Hauptinhalt springen
Dekorationsartikel gehören nicht zum Leistungsumfang.
The Pharmagellan Guide to Analyzing Biotech Clinical Trials
Taschenbuch von Frank S. David
Sprache: Englisch

68,80 €*

inkl. MwSt.

Versandkostenfrei per Post / DHL

Aktuell nicht verfügbar

Kategorien:
Beschreibung
If you work in or around biotech, you're supposed to understand clinical trial results. But what if you're not an expert in study design or biostatistics? You may feel out of your comfort zone when faced with a journal article, press release, or investor presentation.

The Pharmagellan Guide to Analyzing Biotech Clinical Trials is a comprehensive primer to help non-experts evaluate clinical studies of new therapies.Structured roadmap for assessing the main components of a planned or completed biotech trial.
Clear explanations of the most common concepts and terms in biotech clinical studies, illustrated with over 100 real-world examples.
Deep dives on essential topics like p values, sample size calculations, and Kaplan-Meier curves, written in plain English for non-statisticians.
Pointers for interpreting positive and negative study results, understanding common figures and tables, and identifying red flags in press releases.

If you're a biotech executive, investor, advisor, or entrepreneur - or aspire to be one - this handbook will give you the foundation you need to analyze planned and completed clinical trials with more confidence.
If you work in or around biotech, you're supposed to understand clinical trial results. But what if you're not an expert in study design or biostatistics? You may feel out of your comfort zone when faced with a journal article, press release, or investor presentation.

The Pharmagellan Guide to Analyzing Biotech Clinical Trials is a comprehensive primer to help non-experts evaluate clinical studies of new therapies.Structured roadmap for assessing the main components of a planned or completed biotech trial.
Clear explanations of the most common concepts and terms in biotech clinical studies, illustrated with over 100 real-world examples.
Deep dives on essential topics like p values, sample size calculations, and Kaplan-Meier curves, written in plain English for non-statisticians.
Pointers for interpreting positive and negative study results, understanding common figures and tables, and identifying red flags in press releases.

If you're a biotech executive, investor, advisor, or entrepreneur - or aspire to be one - this handbook will give you the foundation you need to analyze planned and completed clinical trials with more confidence.
Über den Autor
Frank S. David, MD, PhD, is the founder and managing director of the biotech consultancy Pharmagellan.
Details
Erscheinungsjahr: 2022
Fachbereich: Allgemeines
Genre: Wirtschaft
Rubrik: Recht & Wirtschaft
Medium: Taschenbuch
ISBN-13: 9780998407524
ISBN-10: 0998407526
Sprache: Englisch
Ausstattung / Beilage: Paperback
Einband: Kartoniert / Broschiert
Autor: David, Frank S.
Hersteller: Pharmagellan, LLC
Maße: 229 x 152 x 18 mm
Von/Mit: Frank S. David
Erscheinungsdatum: 01.02.2022
Gewicht: 0,478 kg
Artikel-ID: 121180293
Über den Autor
Frank S. David, MD, PhD, is the founder and managing director of the biotech consultancy Pharmagellan.
Details
Erscheinungsjahr: 2022
Fachbereich: Allgemeines
Genre: Wirtschaft
Rubrik: Recht & Wirtschaft
Medium: Taschenbuch
ISBN-13: 9780998407524
ISBN-10: 0998407526
Sprache: Englisch
Ausstattung / Beilage: Paperback
Einband: Kartoniert / Broschiert
Autor: David, Frank S.
Hersteller: Pharmagellan, LLC
Maße: 229 x 152 x 18 mm
Von/Mit: Frank S. David
Erscheinungsdatum: 01.02.2022
Gewicht: 0,478 kg
Artikel-ID: 121180293
Warnhinweis

Ähnliche Produkte

Ähnliche Produkte